Origin Therapeutics Holdings (XCNQ:ORIG) EBIT per Share : C$-0.01 (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings EBIT per Share?

Origin Therapeutics Holdings's EBIT per Share for the three months ended in Jun. 2023 was C$-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was C$-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Origin Therapeutics Holdings's EBIT per Share or its related term are showing as below:

XCNQ:ORIG's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Origin Therapeutics Holdings's EBIT for the three months ended in Jun. 2023 was C$-0.09 Mil.

Origin Therapeutics Holdings EBIT per Share Historical Data

The historical data trend for Origin Therapeutics Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings EBIT per Share Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

EBIT per Share

-0.02

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBIT per Share	Get a 7-Day Free Trial				-	-0.01	-	-	-

Origin Therapeutics Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Origin Therapeutics Holdings's EBIT per Share for the fiscal year that ended in Sep. 2022 is calculated as

	EBIT per Share		(A: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.017	/	56.563
=	-0.02

Origin Therapeutics Holdings's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.092	/	56.563
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

Origin Therapeutics Holdings (XCNQ:ORIG) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Origin Therapeutics Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.